Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Dec 11
Love0

Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis

By Chuck Lin No Comments
INTRODUCTIONAxillary hyperhidrosis is a chronic dermatological condition characterized by excessive underarm sweating, often interfering with daily activities.1 It is relatively common, with a prevalence of nearly 5.75%.1 Despite substantial impacts…
Read More
Nov 30
Love0

Impact of Low-Dose Oral Minocycline (DFD-29) on Skin, Gastrointestinal, and Vaginal Microflora in Healthy Adults

By Chuck Lin No Comments
INTRODUCTIONRosacea is a chronic inflammatory facial skin disease that affects 5% to 10% of the population and can adversely affect quality of life.1,2 Common signs and symptoms of rosacea include…
Read More
Nov 30
Love0

Skin Improvements in Acne Vulgaris Patients Using Gel-Matrix Moisturizer as a Complement to Topical Treatments

By Chuck Lin No Comments
INTRODUCTIONWith an estimated prevalence of 9.4% globally, acne vulgaris (hereafter referred to as acne) is one of the most common cutaneous diseases worldwide, with one of the highest disease burdens…
Read More
Nov 30
Love0

Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation

By Chuck Lin No Comments
INTRODUCTIONPigmentary disorders, including melasma, post-inflammatory hyperpigmentation (PIH), solar lentigines, axillary hyperpigmentation, periorbital hyperpigmentation, and vitiligo, are some of the most commonly reported dermatological skin disorders, which significantly impact patients' quality…
Read More
Nov 30
Love0

INDIVIDUAL ARTICLE: NECOM 7: Real-World Cases on Preventive and Treatment Using Skin Care for Cancer Treatment-Related Skin Reactions

By Chuck Lin No Comments
INTRODUCTIONThe current risk of getting cancer before age 80 in Nordic countries is estimated at 42.7% in males and 36.2% in females. Based on the collaborative Nordic cancer registry (NORDCAN),…
Read More
Nov 30
Love0

FDA Boxed Warnings: Should Package Inserts Include Levels of Evidence?

By Chuck Lin No Comments
INTRODUCTION New medications are continuously being developed for the treatment of various disorders. The US Food and Drug Administration (FDA) is the regulatory body responsible for protecting public and individual…
Read More
Nov 30
Love0

FULL SUPPLEMENT: Nordic European Cutaneous Oncodermatology Management (Necom) 7: Real-World Cases Applying Recommendations for the Prevention and Treatment of Skin Reactions Related to Cancer Therapies Using Skin-Protective Measures

By Chuck Lin No Comments
In this issue:NECOM 7: Real-World Cases on Preventive and Treatment Using Skin Care for Cancer Treatment-Related Skin ReactionsAs cancer prevalence continues to increase in Nordic countries, the amount of dermatological…
Read More
Nov 28
Love0

Evaluating the Risk of Atherosclerotic Cardiovascular Disease in Inflammatory Skin Disease: Insights From a TriNetX Cohort Study

By Chuck Lin No Comments
INTRODUCTIONAtherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality worldwide and demands early identification and tailored risk reduction strategies.1 Randomized controlled trials have established the efficacy of…
Read More
Nov 28
Love0

Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting

By Chuck Lin No Comments
INTRODUCTIONInternational Dermatology Outcome Measures (IDEOM) is a nonprofit organization dedicated to developing validated patient-reported outcome measures PROMs (patient-reported outcome measures) for dermatologic research and clinical practice. IDEOM comprises a diverse…
Read More
Nov 28
Love0

GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities

By Chuck Lin No Comments
INTRODUCTIONHidradenitis suppurativa (HS) is a chronic inflammatory skin condition associated with significant physical, economic, and psychosocial burdens.1 It is characterized by painful follicular occlusions, primarily at intertriginous locations, which can…
Read More
Nov 26
Love0

Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne: A Pooled Analysis by Age

By Chuck Lin No Comments
INTRODUCTION Acne vulgaris is one of the most common skin disorders, with an estimated global prevalence of >9% across all ages.1 In part because onset is often associated with puberty-related…
Read More
Nov 25
Love0

Disparities in Hidradentitis Suppurativa Clinical Trials: An Updated Review of ClinicalTrials.gov from 2020 to 2024

By Chuck Lin No Comments
INTRODUCTIONHidradenitis suppurativa (HS) is a chronic skin disease characterized by debilitating symptoms associated with the highest comorbidity burden and lowest quality of life among dermatologic conditions.1 HS largely affects the…
Read More
NextPrevious »

Search page

Advertisement

Popular

  • GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities December 14, 2025
  • Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis December 11, 2025
  • The Overlooked Burden: Psychodermatologic Needs of Hispanic and Latinx Communities in the United States December 10, 2025
  • 2025 JDD Welcome Kit December 9, 2025
  • Perceptions and Recommendations for Sunscreen: A Cross-Sectional Survey of United States Dermatology Healthcare Providers December 8, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search